Pricing
InflaRx
Contact
No bio yet
Timothy E. Hermes
VP, Commercial
Mark Rigsby
Regional Account Director
3 people, 0 jobs
This person is not in any offices
InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.
Industries
Headquarters
Employees
Links
Ampersand
Veza Digital
Scout Financial
Distribusion Technologies
Polyfuze® - Labeling Solutions
View more